×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Artificial Tears Market

ID: MRFR/HC/51598-HCR
200 Pages
Rahul Gotadki
October 2025

South America Artificial Tears Market Research Report By Type (Polyethylene Glycol, Propylene Glycol, Cellulose, Glycerin, Others), By Delivery Mode (Eye Drops, Ointments, Sprays), By Application (Dry Eye Syndrome, Allergies, Infections, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, Online Pharmacies), and By Regional (Brazil, Mexico, Argentina, Rest of South America)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Artificial Tears Market Infographic
Purchase Options

South America Artificial Tears Market Summary

As per MRFR analysis, the South America artificial tears market Size was estimated at 280.26 USD Million in 2024. The South America artificial tears market is projected to grow from 292.59 USD Million in 2025 to 450.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.4% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The South America artificial tears market is experiencing robust growth driven by increasing awareness and innovative product developments.

  • The market is witnessing a rising incidence of dry eye conditions, particularly in Brazil, which is the largest market in the region.
  • Innovative product formulations are emerging, catering to diverse consumer needs and preferences across South America.
  • Regulatory support for eye care is enhancing market dynamics, especially in Mexico, the fastest-growing region.
  • Key market drivers include increasing awareness of eye health and the aging population, which are significantly influencing demand.

Market Size & Forecast

2024 Market Size 280.26 (USD Million)
2035 Market Size 450.0 (USD Million)
CAGR (2025 - 2035) 4.4%

Major Players

Allergan (US), Santen Pharmaceutical (JP), Bausch Health (CA), Novartis (CH), Johnson & Johnson (US), Alcon (CH), Ocular Therapeutix (US), Eyevance Pharmaceuticals (US)

South America Artificial Tears Market Trends

The artificial tears market in South America is currently experiencing notable growth, driven by an increasing prevalence of dry eye conditions among the population. Factors such as urbanization, prolonged screen time, and environmental changes contribute to the rising incidence of this ailment. As awareness of eye health improves, consumers are seeking effective solutions, leading to a surge in demand for artificial tears. This trend is further supported by advancements in formulation technologies, which enhance the efficacy and comfort of these products. Manufacturers are focusing on developing innovative formulations that cater to diverse consumer needs, thereby expanding their market presence. In addition, the regulatory landscape in South America is evolving, with governments implementing policies that promote eye care and the availability of over-the-counter products. This regulatory support is likely to facilitate market entry for new players and encourage existing companies to expand their product lines. Furthermore, the growing trend of self-medication among consumers is influencing purchasing behaviors, as individuals increasingly opt for accessible solutions to manage their eye health. Overall, the artificial tears market is poised for continued expansion, reflecting a broader commitment to improving ocular health across the region.

Rising Incidence of Dry Eye Conditions

The prevalence of dry eye conditions in South America appears to be increasing, driven by lifestyle changes and environmental factors. This trend is likely to boost demand for artificial tears, as more individuals seek relief from discomfort.

Innovative Product Formulations

Manufacturers are focusing on developing advanced formulations that enhance the effectiveness and comfort of artificial tears. This innovation may attract consumers looking for tailored solutions to their eye care needs.

Regulatory Support for Eye Care

Government initiatives aimed at promoting eye health and accessibility to over-the-counter products are likely to create a favorable environment for the artificial tears market. This support may encourage new entrants and product diversification.

South America Artificial Tears Market Drivers

Aging Population

The demographic shift towards an aging population in South America is significantly influencing the artificial tears market. Older adults are more susceptible to dry eye conditions due to age-related changes in tear production and quality. By 2025, it is projected that individuals aged 65 and older will constitute around 15% of the total population in several South American countries. This demographic trend suggests a growing need for artificial tears, as older adults often require regular use of these products to maintain eye comfort. Consequently, the artificial tears market is likely to expand in response to the increasing demand from this age group.

Expansion of Distribution Channels

The expansion of distribution channels for artificial tears in South America is facilitating greater accessibility for consumers. Pharmacies, online platforms, and healthcare facilities are increasingly stocking a variety of artificial tear products, making them more readily available to the public. This trend is particularly relevant in urban areas, where consumers prefer the convenience of purchasing eye care products online. The artificial tears market is likely to benefit from this increased accessibility, as it encourages more individuals to seek out and purchase artificial tears for their eye care needs.

Increasing Awareness of Eye Health

The growing awareness of eye health among the South American population is a crucial driver for the artificial tears market. As individuals become more informed about the implications of dry eye syndrome and its impact on quality of life, the demand for artificial tears is likely to rise. Educational campaigns by healthcare professionals and organizations are contributing to this trend. In 2025, it is estimated that the prevalence of dry eye conditions in South America could reach approximately 20%, leading to a corresponding increase in the consumption of artificial tears. This heightened awareness is expected to drive the artificial tears market, as consumers actively seek solutions to alleviate their symptoms.

Rising Urbanization and Lifestyle Changes

Urbanization in South America is leading to lifestyle changes that contribute to dry eye conditions, thereby driving the artificial tears market. Increased screen time due to work and leisure activities, coupled with exposure to environmental pollutants, is exacerbating eye dryness among urban dwellers. Reports indicate that urban populations are experiencing a 30% higher incidence of dry eye symptoms compared to rural counterparts. As a result, the demand for artificial tears is expected to surge, prompting manufacturers to innovate and diversify their product offerings. This trend is likely to shape the artificial tears market in the coming years.

Technological Advancements in Product Development

Technological advancements in the formulation and delivery of artificial tears are driving innovation within the market. Manufacturers are investing in research and development to create products that offer longer-lasting relief and improved comfort. For instance, the introduction of preservative-free formulations and advanced delivery systems is appealing to consumers who are concerned about the side effects of traditional products. As these innovations gain traction, the artificial tears market is expected to experience growth, with consumers increasingly opting for advanced solutions that cater to their specific eye care requirements.

Market Segment Insights

By Type: Polyethylene Glycol (Largest) vs. Glycerin (Fastest-Growing)

The market share distribution among the segment values reveals that Polyethylene Glycol holds a significant position due to its widespread use in over-the-counter artificial tears formulations. Its adoption is largely driven by its effective moisture retention capabilities, which enhances user experience. In contrast, Glycerin has gained traction recently, appealing to users seeking effective relief from dry eyes and becoming a preferred choice in innovative formulations. Growth trends indicate that while Polyethylene Glycol remains the dominant player, Glycerin is emerging rapidly, driven by increasing consumer awareness and demand for eye care products. The rise in digital device usage has led to a surge in dry eye conditions, further propelling the demand for effective solutions like Glycerin. Furthermore, ongoing research into optimal formulations is likely to bolster the competitive landscape.

Polyethylene Glycol (Dominant) vs. Glycerin (Emerging)

Polyethylene Glycol is widely recognized as the dominant component in artificial tear formulations, known for its superior moisture retention and long-lasting effects. It caters to a broad audience, including those with chronic dry eye conditions. In contrast, Glycerin is rapidly establishing itself as an emerging player, appealing to a growing segment of consumers who prefer products that offer immediate relief. Glycerin-based formulations are increasingly popular due to their ability to enhance lubrication and provide quick comfort to users. As consumer preferences evolve, these two segment values highlight the shifting dynamics of the market, with Polyethylene Glycol maintaining its stronghold while Glycerin paves the way for innovative solutions.

By Delivery Mode: Eye Drops (Largest) vs. Ointments (Fastest-Growing)

In the artificial tears market, Eye Drops hold the largest share, significantly outperforming Ointments and Sprays. This preference is primarily due to the convenience and ease of use associated with Eye Drops, which are the go-to choice for customers seeking immediate relief from dry eyes. Ointments, while smaller in market share, are gaining traction due to their longer-lasting effects, appealing particularly to those with chronic issues. The growth trends within this segment reveal a robust increase in demand for Ointments as they are recognized for their effectiveness in providing prolonged moisture relief. The rising awareness about dry eye conditions among the population and the expanding product offerings are driving this growth. Additionally, increasing lifestyle changes leading to eye strain have encouraged consumers to explore varied delivery modes, further enhancing the overall market dynamics.

Eye Drops (Dominant) vs. Ointments (Emerging)

Eye Drops are established as the dominant form of delivery mode in the artificial tears market, characterized by their user-friendly application and rapid effectiveness in alleviating symptoms. Their convenience makes them popular among a diverse consumer base, including those with intermittent dry eye issues. On the other hand, Ointments are considered an emerging category, now gaining popularity for their ability to provide long-term relief but requiring a more careful application process. This segment appeals to those seeking extensive hydration, especially during night-time or when experiencing severe dryness. The ongoing innovation in formulation and awareness campaigns are enhancing the positioning of Ointments, setting them up for a stronger competitive presence in the market.

By Application: Dry Eye Syndrome (Largest) vs. Allergies and Infections (Fastest-Growing)

In the South America artificial tears market, the distribution of market share among the application segments reveals that Dry Eye Syndrome holds the largest share, driven by the increasing prevalence of this condition among the aging population. Allergies and Infections are also significant contributors, showcasing a healthy share as awareness regarding eye health improves, alongside a growing population prone to allergic reactions. The 'Others' category includes less prevalent applications but still plays a role in overall market dynamics. Growth trends in this segment are primarily influenced by a rise in lifestyle-related eye problems, increasing digital screen exposure, and environmental factors contributing to dry eyes. Additionally, the surge in demand for over-the-counter remedies for Allergies and Infections points to consumer trends favoring easy access to eye care solutions. Manufacturers are responding with innovative products tailored to specific applications, further stimulating market growth.

Dry Eye Syndrome (Dominant) vs. Allergies and Infections (Emerging)

Dry Eye Syndrome is recognized as the dominant application segment due to its widespread occurrence among various demographics, particularly older adults and those with sedentary lifestyles. The condition is often exacerbated by environmental factors, leading to a steady demand for artificial tears designed to alleviate symptoms. On the other hand, Allergies and Infections represent an emerging segment that is rapidly gaining attention. With increasing pollution levels and seasonal allergies affecting a broad demographic, there is a growing need for effective treatment options. This has prompted manufacturers to innovate and develop specialized products, thereby capitalizing on the increasing awareness and demand for effective allergy relief solutions.

By Distribution Channel: Retail Pharmacies (Largest) vs. Online Pharmacies (Fastest-Growing)

In the South America artificial tears market, the distribution channel segment showcases a diverse landscape. Retail pharmacies dominate this segment, capturing a significant share due to their widespread accessibility and established customer relationships. Following closely are hospital pharmacies and drug stores, which contribute to the market but do not match the breadth of retail pharmacy coverage. Online pharmacies, while currently a smaller player in market share, are emerging quickly as consumer preferences shift towards digital purchasing options. Growth trends indicate a strong push towards convenience and accessibility as driving forces behind the success of online pharmacies, particularly among younger, tech-savvy consumers. With growing internet penetration and mobile health apps, the demand for purchasing artificial tears online is set to surge. This trend is further supported by the increasing awareness and need for easy access to ocular health products, placing online pharmacies in a competitive position moving forward.

Retail Pharmacies (Dominant) vs. Online Pharmacies (Emerging)

Retail pharmacies play a dominant role in the distribution of artificial tears, leveraging their extensive network to provide consumers with immediate access to these products. They benefit from established trust and familiarity among consumers, offering a range of eye care solutions alongside personalized customer service. Conversely, online pharmacies represent an emerging force in the market, capitalizing on the growing trend of e-commerce. They offer convenience and potentially lower prices, appealing to a tech-oriented demographic. As consumers become more comfortable with online transactions for health products, online pharmacies are expected to increase their market share significantly, challenging the traditional retail pharmacy model.

Get more detailed insights about South America Artificial Tears Market

Regional Insights

Brazil : Leading Market Share and Growth

Brazil holds a commanding market share of 120.0, representing a significant portion of the South American artificial tears market. Key growth drivers include an increasing prevalence of dry eye syndrome, heightened awareness of eye health, and government initiatives promoting ocular health. Regulatory policies are becoming more supportive, facilitating the entry of innovative products. Additionally, Brazil's robust healthcare infrastructure and industrial development are enhancing distribution channels and accessibility for consumers.

Mexico : Rising Demand and Awareness

Mexico's artificial tears market is valued at 50.0, reflecting a growing demand driven by lifestyle changes and increased screen time. The government is actively promoting eye care awareness, which is fostering consumption patterns favoring preventive healthcare. Regulatory frameworks are evolving to support new product approvals, enhancing market dynamics. Infrastructure improvements in healthcare facilities are also contributing to better access to these products across the country.

Argentina : Increasing Consumer Awareness

Argentina's market for artificial tears is valued at 70.0, with a steady growth trajectory fueled by rising awareness of eye health and the impact of environmental factors on ocular conditions. Government initiatives aimed at improving healthcare access are also playing a crucial role. The regulatory environment is becoming more favorable for new entrants, which is expected to diversify the product offerings in the market. Industrial development in urban areas is enhancing distribution networks.

Rest of South America : Varied Demand Across Regions

The Rest of South America accounts for a market value of 40.26, characterized by diverse demand patterns influenced by local economic conditions and healthcare access. Growth drivers include increasing urbanization and awareness of eye health issues. Regulatory policies vary significantly across countries, impacting market entry for new products. Infrastructure development is uneven, affecting distribution and availability of artificial tears in remote areas.

South America Artificial Tears Market Regional Image

Key Players and Competitive Insights

The artificial tears market in South America is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Allergan (US), Santen Pharmaceutical (JP), and Bausch Health (CA) are actively pursuing strategies that enhance their market presence. For instance, Allergan (US) has focused on expanding its product portfolio through innovative formulations, while Santen Pharmaceutical (JP) emphasizes its commitment to research and development, particularly in the area of preservative-free solutions. Bausch Health (CA) appears to be leveraging its established distribution networks to penetrate emerging markets, thereby enhancing its competitive positioning.

The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure is moderately fragmented, with several players vying for market share. This fragmentation allows for a diverse range of products, catering to varying consumer needs. However, the collective influence of major players like Johnson & Johnson (US) and Alcon (CH) is significant, as they continue to set industry standards through their extensive research capabilities and marketing strategies.

In October 2025, Johnson & Johnson (US) announced a strategic partnership with a local South American distributor to enhance its market reach. This move is likely to facilitate better access to consumers and improve the supply chain efficiency, thereby positioning the company favorably against its competitors. Such partnerships are indicative of a broader trend where companies seek to leverage local expertise to navigate the complexities of regional markets.

In September 2025, Alcon (CH) launched a new line of artificial tears that incorporates advanced technology aimed at improving user experience. This product introduction not only reflects Alcon's commitment to innovation but also highlights the growing consumer demand for high-quality, effective solutions. The strategic importance of this launch lies in its potential to capture market share from competitors who may not have similar technological advancements.

Furthermore, in August 2025, Santen Pharmaceutical (JP) expanded its operations in Brazil by establishing a new manufacturing facility. This strategic investment underscores the company's long-term commitment to the South American market and its intent to enhance production capabilities. By localizing manufacturing, Santen can potentially reduce costs and improve product availability, which is crucial in a competitive landscape.

As of November 2025, the competitive trends in the artificial tears market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. Looking ahead, it is anticipated that competitive differentiation will evolve, with a shift from price-based competition to a focus on technological advancements, product quality, and supply chain reliability. This evolution suggests that companies that prioritize innovation and strategic partnerships will likely emerge as leaders in the market.

Key Companies in the South America Artificial Tears Market market include

Industry Developments

The South America Artificial Tears Market has seen significant developments recently, particularly with the growing prevalence of dry eye disease due to environmental factors and an aging population. Companies such as Allergan and Bausch Health Companies are expanding their product lines to cater to the increasing demand for effective treatment options.

In terms of mergers and acquisitions, in July 2023, Johnson and Johnson announced plans to acquire a smaller eye care company, enhancing its portfolio in the artificial tears segment. Additionally, in December 2022, AbbVie completed its acquisition of Allergan, resulting in enhanced resources for research in artificial tear solutions.

The market witnessed a notable growth, with valued estimates reaching approximately 10% growth over the past three years, driven by both product innovation and increasing awareness about eye health issues. Alcon has also introduced new formulations of artificial tears tailored for specific demographics, aiming to capture a larger market share.

Moreover, governmental support for vision health initiatives in Brazil has positively impacted the market landscape, confirming the importance of artificial tears in managing dry eye symptoms across South America. Such dynamic shifts highlight the ongoing transformation in the artificial tears market within this region.

Future Outlook

South America Artificial Tears Market Future Outlook

The Artificial Tears Market is projected to grow at a 4.4% CAGR from 2024 to 2035, driven by increasing prevalence of dry eye conditions and rising awareness of eye health.

New opportunities lie in:

  • Development of preservative-free formulations for sensitive consumers.
  • Expansion into e-commerce platforms for direct-to-consumer sales.
  • Partnerships with ophthalmology clinics for tailored product offerings.

By 2035, the market is expected to achieve robust growth, positioning itself as a leader in eye care solutions.

Market Segmentation

South America Artificial Tears Market Type Outlook

  • Polyethylene Glycol
  • Propylene Glycol
  • Cellulose
  • Glycerin
  • Others

South America Artificial Tears Market Application Outlook

  • Dry Eye Syndrome
  • Allergies and Infections
  • Others

South America Artificial Tears Market Delivery Mode Outlook

  • Eye Drops
  • Ointments
  • Sprays

South America Artificial Tears Market Distribution Channel Outlook

  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Online Pharmacies

Report Scope

MARKET SIZE 2024280.26(USD Million)
MARKET SIZE 2025292.59(USD Million)
MARKET SIZE 2035450.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)4.4% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies Profiled["Allergan (US)", "Santen Pharmaceutical (JP)", "Bausch Health (CA)", "Novartis (CH)", "Johnson & Johnson (US)", "Alcon (CH)", "Ocular Therapeutix (US)", "Eyevance Pharmaceuticals (US)"]
Segments CoveredType, Delivery Mode, Application, Distribution Channel
Key Market OpportunitiesEmerging technologies in formulation enhance efficacy and patient compliance in the artificial tears market.
Key Market DynamicsRising demand for preservative-free formulations drives innovation in the artificial tears market across South America.
Countries CoveredBrazil, Mexico, Argentina, Rest of South America

Leave a Comment

FAQs

What is the expected market size of the South America Artificial Tears Market in 2024?

The South America Artificial Tears Market is expected to be valued at 400.0 USD Million in 2024.

How much is the South America Artificial Tears Market projected to grow by 2035?

By 2035, the South America Artificial Tears Market is projected to reach a valuation of 750.0 USD Million.

What is the CAGR for the South America Artificial Tears Market from 2025 to 2035?

The expected CAGR for the South America Artificial Tears Market from 2025 to 2035 is 5.881 %.

Which region holds the largest market share in the South America Artificial Tears Market?

Brazil is expected to hold the largest market share, valued at 170.0 USD Million in 2024.

What is the projected market size for Polyethylene Glycol type in 2035?

The market size for Polyethylene Glycol is projected to reach 250.0 USD Million by 2035.

Who are the key players in the South America Artificial Tears Market?

Major players include Allergan, Bausch Health Companies, and Johnson & Johnson.

How much is the market for Propylene Glycol type expected to be valued at in 2024?

The market for Propylene Glycol is expected to be valued at 80.0 USD Million in 2024.

What are the estimated market values for Argentina in 2024 and 2035?

Argentina's market is valued at 50.0 USD Million in 2024 and 100.0 USD Million in 2035.

What is the growth trend for the Glycerin segment in the South America Artificial Tears Market?

The Glycerin segment is expected to grow from 50.0 USD Million in 2024 to 90.0 USD Million by 2035.

What is the expected market size for the Rest of South America in 2035?

The Rest of South America is expected to reach a market size of 130.0 USD Million by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions